Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT03884205
Eligibility Criteria:
Inclusion Criteria:
* Peripheral T Cell Lymphoma, Not Otherwise Specified
* Angioimmunoblastic T Cell Lymphoma
* ALK-negative Anaplastic Large Cell Lymphoma
* Enteropathy Associated T Cell Lymphoma
* Subcutaneous Panniculitis Like T Cell Lymphoma
* Acute T-cell Leukemia/Lymphoma
Exclusion Criteria:
* woman in pregnancy or lactation
* allergic to any intervention drug
* unsuitable to the study due to severe complication
* enrolled to other study during the past 6 months
* NK/T lymphoma ALK-positive Anaplastic Large Cell Lymphoma
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
75 Years
Study:
NCT03884205
Study Brief:
Protocol Section:
NCT03884205